HOOKIPA Pharma to Participate in the HC Wainwright 26th Annual Global Investment Conference

HOOKIPA Pharma Announces Participation in Upcoming Event

Key Points:

* HOOKIPA Pharma will attend the HC Wainwright 26th Annual Global Investment Conference. * The conference will take place from May 23-26, 2024, in Miami Beach, Florida. * HOOKIPA Pharma is a clinical-stage biopharmaceutical company developing a new class of therapies for cancer and other diseases.

HOOKIPA Pharma Inc. (NASDAQ: HOOK), a clinical-stage biopharmaceutical company, has announced its participation in the upcoming HC Wainwright 26th Annual Global Investment Conference. The conference will be held from May 23-26, 2024, at the Fontainebleau Miami Beach in Miami Beach, Florida.

HOOKIPA Pharma's management team will be presenting at the conference and will be available to meet with investors and analysts to discuss the company's pipeline and recent developments. The company's presentation is scheduled for Tuesday, May 24, 2024, at 10:00 AM Eastern Time.

HOOKIPA Pharma is a clinical-stage biopharmaceutical company focused on the development of novel immunotherapies for cancer and other diseases. The company's lead product candidate, HOOK201, is a first-in-class antibody that targets the CD47 protein, which is overexpressed on many cancer cells.